🏦 UAE Regulator Approves AstraZeneca’s Ultomiris for IgA Nephropathy The Emirates Drug Establishment (EDE) has authorized a new indication for AstraZeneca’s Ultomiris to manage proteinuria in adult patients. 🔗 Read the full story on GazeWire #Economy #UAE #Biotech #GazeWire
Private to this visit. Text and context are processed by AI.